3 Cost Considerations to Enhance Prescription Market Access

3 Cost Considerations to Enhance Prescription Market Access

Gaining prescription #marketaccess is increasingly challenging, but these three solutions from THIS VALUATE WHITE PAPER can help you achieve your goals:

• Consider variable cost-sharing (e.g., sliding scale based on income) when it comes to benefit offerings
• Adjust cost-sharing models in disease states by which at-risk populations are disproportionally affected
• Realize that medication costs aren’t the only concern; framing the real financial picture patients face when covering the cost of their care (e.g., other care-related expenses at play) is key to addressing health disparities

Discover more strategies to gain prescription market access here.

ICYMI: All Eyes on Data Optimization for Specialty Pharmacy

Data optimization is increasingly at the forefront for specialty pharmacy, according to Valuate consultant Derek Tancredi. Speaking to The IDI podcast, Tancredi said this year’s recently-wrapped Asembia annual conference was full of sessions focused on leveraging #dataoptimization for #specialtypharmacy.

Tancredi explained why data will continue to be such a valuable tool to improve market access:

• Understanding patient longitudinality. “Organizations are looking to measure specific drug outcomes over time and utilize this info to enhance decision-making,” Tancredi said.
• Understanding payer reimbursement trends. “Payers are relying on this data more and more to inform reimbursement decisions but also this data gives organizations an idea of how long it will take to reimburse a new drug that comes to market,” he added.

Listen for more insights here.

New Market Access Podcast: The IDI by Valuate

Need a companion while commuting to work, traveling for business, or even exercising at home? Valuate Health Consultancy recently launched The IDI, a podcast for market access professionals.

The IDI offers in-depth interviews to uncover payer insights that help drive market access solutions.

Recent episodes touched on:

• Oncology and Cancer Care
• ?Specialty Pharmacy
• Data optimization
• Biosimilars
• ?Industry news and events

Listen on Apple or Spotify.